MET-233I
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Pfizer · Phase 1/2 · Completed · Enrollment 201
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Part A Cohort | n/r | n/r | n/r | n/r | n/r |
| Part B Cohort | n/r | n/r | n/r | n/r | n/r |
| Part C Cohort | n/r | n/r | n/r | n/r | n/r |
| Part D Cohort | n/r | n/r | n/r | n/r | n/r |
| Part E Cohort | n/r | n/r | n/r | n/r | n/r |
| Part G Cohort | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.